从骨髓来源的巨噬细胞中鉴定小细胞外囊泡的肽
June 30th, 2023
该协议描述了通过差异超速离心从巨噬细胞中分离小细胞外囊泡并提取肽圆顶以进行质谱鉴定的程序。
我们探索细胞外囊泡在先天免疫中的功能作用。我们开发了一种通过差示超速离心分离小细胞外囊泡（sEV）的方案，并通过LC-MS / MS鉴定肽球，揭示了sEV中肽的关键生物学功能。细胞外囊泡已被证明可以通过将货物运输到受体细胞（如蛋白质、脂质和核酸）来介导细胞间通讯。
通过释放抗菌成分，它们在先天免疫中充当抵御入侵微生物的第一道防线。虽然差示超速离心可产生高纯度的小细胞外sEV，但它可能非常耗时，并且通常会导致低产量。在我们的研究中，这些是稳定鉴定sEV中低丰度肽的主要挑战。
View the full transcript and gain access to thousands of scientific videos
概述
本研究提出了一种通过差速超速离心法从巨噬细胞中分离小型细胞外囊泡（sEVs）的协议。然后提取这些囊泡的肽组，并通过质谱分析进行鉴定，突出了它们在先天免疫中的作用。
关键研究组成部分
科学领域
- 神经科学
- 免疫学
- 细胞生物学
背景
- 细胞外囊泡对细胞间通讯至关重要。
- 它们运输各种生物分子，包括蛋白质和核酸。
- sEVs通过释放抗微生物成分在先天免疫中发挥重要作用。
- 由于低产量和耗时的过程，分离sEVs可能具有挑战性。
研究目的
- 开发一个从巨噬细胞中可靠分离sEVs的协议。
- 识别sEVs的肽组并了解其生物功能。
- 解决在sEVs中鉴定低丰度肽的挑战。
使用的方法
- 用于sEVs分离的差速超速离心。
- 用于肽组鉴定的质谱分析（LC-MS/MS）。
- 分析sEVs中肽的功能角色。
- 评估分离的sEVs的纯度和产量。
主要结果
- 成功从巨噬细胞中分离出高度纯净的sEVs。
- 鉴定了参与先天免疫反应的关键肽。
- 揭示了sEVs在介导细胞间通讯中的作用。
- 突出了在获得低丰度肽的稳定鉴定方面的挑战。
结论
- 开发的协议增强了sEVs的分离，以便进一步研究。
- 识别肽组提供了对sEVs生物功能的洞察。
- 未来的研究可以集中在提高肽鉴定的产量和稳定性上。
常见问题
Executive Industry Relevance
Systematic identification of the peptidome within small extracellular vesicles (sEVs) from bone marrow-derived macrophages enables deeper mechanistic insight into innate immune signaling and intercellular communication. This workflow addresses a critical discovery-stage challenge: isolating and characterizing low-abundance bioactive peptides that may serve as functional effectors or biomarkers. The approach supports predictive confidence in target validation and informs risk-adjusted portfolio decisions in immunology and cell therapy pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of innate immune pathways mediated by sEV-derived peptides.
- Supports biological de-risking by clarifying peptide cargo functions in macrophage signaling.
- Facilitates predictive confidence in selecting immune-modulatory targets for further study.
Screening & Assay Development
- Provides a validated workflow for isolating highly pure sEVs suitable for downstream peptidomic analysis.
- Establishes reproducible LC-MS/MS-based quantification of endogenous peptides.
- Enables standardization of peptide identification for screening and comparative studies.
Translational & Preclinical Research
- Aligns peptide cargo analysis with disease-relevant immune models.
- Supports continuity from discovery through preclinical validation of immune-modulatory mechanisms.
- Informs translational biomarker strategies by characterizing vesicle-associated peptides.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum by enabling robust peptidome profiling of sEVs, supporting both mechanistic studies and translational research in immunology.
- Discovery Biology: Advances hypothesis testing on the functional roles of sEV peptides in innate immunity.
- Screening: Delivers reproducible, quantitative peptide profiles for comparative analysis.
- Analytics: Employs LC-MS/MS to generate high-confidence peptide identifications and abundance measurements.
- Translational Research: Bridges discovery findings to preclinical immune models by characterizing vesicle cargo.
- Enterprise Reuse: Establishes a reusable platform for sEV peptidome analysis across immune cell types.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in immune target validation and mechanistic de-risking.
- Operational Value: Standardizes sEV isolation and peptidome analysis for reproducibility and scalability.
- Strategic Value: Enables informed go/no-go decisions by clarifying peptide-mediated immune mechanisms.
- Portfolio Impact: Supports risk-adjusted prioritization of immune-modulatory programs.
Implementation Considerations
- Requires expertise in differential ultracentrifugation and LC-MS/MS analytics.
- Demands access to high-speed centrifugation and advanced mass spectrometry infrastructure.
- Necessitates rigorous cross-team standardization for reproducible peptide identification.
- May require adaptation for different cell sources or vesicle subtypes.
- Low yield and time-intensive isolation remain practical limitations for high-throughput applications.
